ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancerJuan Li, Yuping Sun, Shuyi Han et al.|Cancer Letters|2020Cited by 62
Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancerAnqi Wang, Jian‐An Huang, Jianjie Zhu et al.|Cancer Medicine|2020Cited by 38
Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trialYuankai Shi, Huaize Geng, Jian Fang et al.|Signal Transduction and Targeted Therapy|2022Cited by 35